Human medicines European public assessment report (EPAR): Lupkynis, voclosporin, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 20, Status: Authorised

PSUSA/00003159/202512

Agenda of the CVMP meeting 8-10 September 2026

PSUSA/00010710/202601

Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 27, Status: Authorised

Member states contact points for translations review

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 30, Status: Authorised

EMA/FVE information session for veterinary students: the importance of pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 October 2026, 16:00 (CEST) to 13 October 2026, 17:15 (CEST)